Genomic and transcriptomic analysis of imatinib resistance in gastrointestinal stromal tumors

Author:

Takahashi Tsuyoshi1,Elzawahry Asmaa23,Mimaki Sachiyo4,Furukawa Eisaku2,Nakatsuka Rie1,Nakamura Hiromi5,Nishigaki Takahiko1,Serada Satoshi6,Naka Tetsuji6,Hirota Seiichi7,Shibata Tatsuhiro5,Tsuchihara Katsuya4,Nishida Toshirou8,Kato Mamoru23ORCID

Affiliation:

1. Department of Gastroenterological SurgeryOsaka University Graduate School of Medicine2‐2 E2, YamadaokaSuita City Osaka565‐0871 Japan

2. Department of BioinformaticsNational Cancer Center Research Institute5‐1‐1 TsukijiChuo‐ku Tokyo104‐0045 Japan

3. JSTCREST5‐3 YonbanchoChiyoda‐ku Tokyo102‐0081 Japan

4. Division of Translational ResearchExploratory Oncology Research and Clinical Trial Center, National Cancer Center6‐5‐1 KashiwanohaKashiwa Chiba277‐8577 Japan

5. Division of Cancer GenomicsNational Cancer Center Research Institute5‐1‐1 TsukijiChuo‐ku Tokyo104‐0045 Japan

6. Laboratory for Immune SignalNational Institute of Biomedical Innovation7‐6‐8 Saito‐AsagiIbaraki City Osaka567‐0085 Japan

7. Department of Surgical PathologyHyogo Medical College1‐1, Mukogawa‐choNishinomiya City Hyogo663‐8501 Japan

8. Department of SurgeryNational Cancer Center Hospital East6‐5‐1 KashiwanohaKashiwa Chiba277‐8577 Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Core Research for Evolutional Science and Technology

Foundation for Promotion of Cancer Research

Kato Memorial Bioscience Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3